Archive for April 20th, 2010

Apple’s New All-Time Highs (AAPL)

Apple Inc. (NASDAQ: AAPL) has reopened after its trading halt.  The company handily beat earnings estimates and estimates on margins, iPhones, iPods, and iMacs…. and shares are sharply higher.  Shares closed down 1% at $244.59, and the stock is up around $263.00 in the after-hours session.  The prior 52-week and all-time high was $251.14. Keep [...]

Not So Magic After All (MTG)

MGIC Investment Corp. (NYSE: MTG) is getting drilled this morning. The good news is that MGIC’s first quarter loss narrowed and it saw sharply lower claims costs. The problem is that the mortgage insurer said it is going to sell at least $700 million in stock and also $300 million of convertible senior notes in [...]

MGM Analyst Endorsement (MGM)

MGM Mirage (NYSE: MGM) is trading higher this morning on an analyst upgrade that is actually an upgrade of semantics more than an upgrade of stature.  The casino operator was raised to the Conviction Buy List at Goldman Sachs, although the firm already had a Buy rating on MGM. For whatever it is worth, Credit [...]

Human Genome Sciences Runs Into Lupus Concern (HGSI)

Human Genome Sciences Inc. (NASDAQ: HGSI) is trading lower after it and GlaxoSmithKline (NYSE: GSK) announced topline 76-week results of the Phase III BLISS-76 trial of Benlysta in Systemic Lupus Erythematosus…  BENLYSTA already met its primary efficacy endpoint at Week 52 in both BLISS-52 and BLISS-76 studies in July and November 2009; at Week 76 [...]

Array Scores Novartis For Stock Surge (ARRY, NVS)

Array BioPharma, Inc. (NASDAQ: ARRY) is soaring after it secured an alternative to a marger… it has entered into a worldwide partnership covering its cancer drugs with Novartis AG (NYSE: NVS).  The pact calls for a $45 million upfront and milestone payment and the royalties can bring the total deal up to $467 million if [...]

IBM, A Small Bite Out of Big Blue (IBM)

International Business Machines Corp. (NYSE: IBM) is still lower after beating earnings and raising guidance.  The earnings was not bad but was a case of “not beating by enough” and the backlog drop was a concern considering we are supposed to be in a growth mode.  Shares closed at $132.23 and we have shares down [...]

Goldman Trounces Estimates; UK and Compensation Issues (GS)

Goldman Sachs Group Inc. (NYSE: GS) has reported earnings.  The bulge bracket brokerage firm reported 1Q as $5.59 EPS, well above the $4.01 estimates from Thomson Reuters and $4.16 estimates from Dow Jones.  This translates to $3.46 billion in income and revenues were $12.78 billion.  Book Value Per Common Share came in at $122.52 as [...]